whp004

Wayne H. Pinover, DO

Contact Dr. Pinover

Asplundh Cancer Pavilion at Abington Jefferson Health
3941 Commerce Avenue
Willow Grove, PA 19090

(215) 481-2800
(215) 481-6741 fax

Most Recent Peer-reviewed Publications

  1. Implementation of Germline Testing for Prostate Cancer: Philadelphia Prostate Cancer Consensus Conference 2019
  2. Patient Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer
  3. Evaluation of Planned Treatment Breaks During Radiation Therapy for Anal Cancer: Update of RTOG 92-08
  4. Psychoeducational group intervention for wives of men with prostate cancer
  5. Free prostate-specific antigen improves prostate cancer detection in a high-risk population of men with a normal total PSA and digital rectal examination
  6. Validation of a treatment policy for patients with prostate specific antigen failure after three-dimensional conformal prostate radiation therapy
  7. Impact of target volume coverage with Radiation Therapy Oncology Group (RTOG) 98-05 guidelines for transrectal ultrasound guided permanent Iodine-125 prostate implants
  8. Late morbidity profiles in prostate cancer patients treated to 79-84 Gy by a simple four-field coplanar beam arrangement
  9. Biochemical failure rates in prostate cancer patients predicted to have biologically insignificant tumors treated with three-dimensional conformal radiation therapy
  10. Advantages of using noncoplanar vs. axial beam arrangements when treating prostate cancer with intensity-modulated radiation therapy and the step-and-shoot delivery method
  11. Relationship between prostate volume, prostate-specific antigen nadir, and biochemical control
  12. Trimodality therapy for advanced gallbladder cancer
  13. Hypoxia in human prostate carcinoma: An eppendorf PO2 study
  14. Plasma levels of IGF-1, IGF-2, and IGFBP-3 in white and African-American men at increased risk of prostate cancer
  15. Impact of surgery and chemotherapy on the quality of life of younger women with breast carcinoma: A prospective study
  16. Swallowing function and weight change observed in a phase I/II study of external-beam radiation, brachytherapy and concurrent chemotherapy in localized cancer of the esophagus (RTOG 9207)
  17. Patterns and fate of PSA bouncing following 3D-CRT
  18. To move or not to move: Measurements of prostate motion by urethrography using MRI
  19. Re: Simultaneous irradiation for prostate cancer: Intermediate results with modern techniques
  20. Re: Simultaneous irradiation for prostate cancer: Intermediate results with modern techniques [3] (multiple letters)
  21. Effect of Preoperative Chemoradiotherapy on Surgical Margin Status of Resected Adenocarcinoma of the Head of the Pancreas
  22. Outcome and predictive factors for patients with Gleason score 7 prostate carcinoma treated with three-dimensional conformal external beam radiation therapy
  23. Increasing levels of hypoxia in prostate carcinoma correlate significantly with increasing clinical stage and patient age: An Eppendorf pO2 study
  24. Regarding Vicini et al. (multiple letters)
  25. Defining the appropriate radiation dose for pretreatment PSA ≤ 10 ng/mL prostate cancer